← All companiesKKalVista Pharmaceuticals, Inc.
KALV - CIK 0001348911
KalVista Pharmaceuticals, Inc. net income by year
KalVista Pharmaceuticals, Inc. (KALV) reported net income of -$183.40M for fiscal year 2025, as filed in its audited annual report with the SEC.
KALV annual net income
KALV net income 2013-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$183.40M | -44.9% |
| FY 2024 | -$126.60M | -36.3% |
| FY 2023 | -$92.90M | -12.8% |
| FY 2022 | -$82.34M | -78.1% |
| FY 2021 | -$46.24M | -58.8% |
| FY 2020 | -$29.12M | -39.9% |
| FY 2019 | -$20.82M | -31.7% |
| FY 2018 | -$15.80M | +15.0% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does KalVista Pharmaceuticals, Inc. make?
KalVista Pharmaceuticals, Inc. (KALV) reported net income of -$183.40M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has KalVista Pharmaceuticals, Inc.'s net income changed over time?
Between fiscal 2013 and fiscal 2025, KalVista Pharmaceuticals, Inc.'s net income declined from -$5.68M to -$183.40M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.